The second most co-cited reference is the article “Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma,” authored by Flaherty et al., also published in the New England Journal of Medicine (Flaherty et al., 2012). This evidence concerns the gene BRAF and melanoma.